↓ Skip to main content

Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial

Overview of attention for article published in The Lancet, September 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
13 news outlets
blogs
6 blogs
policy
2 policy sources
twitter
51 tweeters
facebook
3 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
130 Dimensions

Readers on

mendeley
244 Mendeley
Title
Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial
Published in
The Lancet, September 2014
DOI 10.1016/s0140-6736(14)61231-9
Pubmed ID
Authors

Michael Sharpe, Jane Walker, Christian Holm Hansen, Paul Martin, Stefan Symeonides, Charlie Gourley, Lucy Wall, David Weller, Gordon Murray

Twitter Demographics

The data shown below were collected from the profiles of 51 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 244 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 4 2%
United States 2 <1%
Spain 1 <1%
Japan 1 <1%
Uruguay 1 <1%
Unknown 235 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 48 20%
Student > Ph. D. Student 35 14%
Student > Master 33 14%
Student > Doctoral Student 22 9%
Student > Bachelor 21 9%
Other 58 24%
Unknown 27 11%
Readers by discipline Count As %
Medicine and Dentistry 77 32%
Psychology 58 24%
Nursing and Health Professions 20 8%
Social Sciences 12 5%
Neuroscience 5 2%
Other 34 14%
Unknown 38 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 173. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2019.
All research outputs
#90,314
of 14,362,853 outputs
Outputs from The Lancet
#1,307
of 33,021 outputs
Outputs of similar age
#1,307
of 200,810 outputs
Outputs of similar age from The Lancet
#24
of 480 outputs
Altmetric has tracked 14,362,853 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,021 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 37.2. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 200,810 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 480 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.